330
Views
21
CrossRef citations to date
0
Altmetric
Review Article

Warfarin and UDP-glucuronosyltransferases: writing a new chapter of metabolism

, &
Pages 55-61 | Accepted 27 Jul 2009, Published online: 14 Jan 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Shenglei Yan, Yuying Liu, Jianfang Feng, Hua Zhao, Zhongshu Yu, Jing Zhao, Yao Li & Jingqing Zhang. (2018) Difference and alteration in pharmacokinetic and metabolic characteristics of low-solubility natural medicines. Drug Metabolism Reviews 50:2, pages 140-160.
Read now
Christian Riebeling, Katrin Hayess, Annelieke K. Peters, Margino Steemans, Horst Spielmann, Andreas Luch & Andrea E. M. Seiler. (2012) Assaying embryotoxicity in the test tube: Current limitations of the embryonic stem cell test (EST) challenging its applicability domain. Critical Reviews in Toxicology 42:5, pages 443-464.
Read now
Michal Šiller, Pavel Anzenbacher, Eva Anzenbacherová, Karel Doležal & Miroslav Strnad. (2011) In vitro interaction of a novel neutrophil growth factor with human liver microsomal cytochromes P450 and the contribution of UDP-glucuronosyltransferases to its metabolism. Xenobiotica 41:11, pages 934-944.
Read now
Petra Jančová, Michal Šiller, Eva Anzenbacherová, Vladimír Křen, Pavel Anzenbacher & Vilím Šimánek. (2011) Evidence for differences in regioselective and stereoselective glucuronidation of silybin diastereomers from milk thistle (Silybum marianum) by human UDP-glucuronosyltransferases. Xenobiotica 41:9, pages 743-751.
Read now

Articles from other publishers (17)

Shen Cheng, Darcy R. Flora, Allan E. Rettie, Richard C. Brundage & Timothy S. Tracy. (2022) Pharmacokinetic Modeling of Warfarin ІI – Model-Based Analysis of Warfarin Metabolites after Warfarin Administered Either Alone or Together with Fluconazole or Rifampin. Drug Metabolism and Disposition 50:9, pages 1302-1311.
Crossref
Dakota L. Pouncey, Dustyn A. Barnette, Riley W. Sinnott, Sarah J. Phillips, Noah R. Flynn, Howard P. Hendrickson, S. Joshua Swamidass & Grover P. Miller. (2022) Discovery of Novel Reductive Elimination Pathway for 10-Hydroxywarfarin. Frontiers in Pharmacology 12.
Crossref
Kazuki Takeda, Yoshinori Ikenaka, Kazuyuki D. Tanaka, Shouta M.M. Nakayama, Tsutomu Tanikawa, Hazuki Mizukawa & Mayumi Ishizuka. (2018) Investigation of hepatic warfarin metabolism activity in rodenticide-resistant black rats (Rattus rattus) in Tokyo by in situ liver perfusion. Pesticide Biochemistry and Physiology 148, pages 42-49.
Crossref
Xia-Wen Liu, Yi Rong, Xing-Fei Zhang, Jun-Jun Huang, Yi Cai, Bi-Yun Huang, Liu Zhu, Bo Wu, Ning Hou & Cheng-Feng Luo. (2018) Human UDP-Glucuronosyltransferase 2B4 and 2B7 Are Responsible for Naftopidil Glucuronidation in Vitro. Frontiers in Pharmacology 8.
Crossref
Kazuki Takeda, Yoshinori Ikenaka, Tsutomu Tanikawa, Kazuyuki D. Tanaka, Shouta M.M. Nakayama, Hazuki Mizukawa & Mayumi Ishizuka. (2016) Novel revelation of warfarin resistant mechanism in roof rats (Rattus rattus) using pharmacokinetic/pharmacodynamic analysis. Pesticide Biochemistry and Physiology 134, pages 1-7.
Crossref
Sook Hee An, Byung Chul Chang, Kyung Eun Lee & Hye Sun Gwak. (2015) Influence of UDP-Glucuronosyltransferase Polymorphisms on Stable Warfarin Doses in Patients with Mechanical Cardiac Valves. Cardiovascular Therapeutics 33:6, pages 324-328.
Crossref
Jacqueline A. Gibbons, Michiel de Vries, Walter Krauwinkel, Yoshiaki Ohtsu, Jan Noukens, Jan-Stefan van der Walt, Roelof Mol, Joyce Mordenti & Taoufik Ouatas. (2015) Pharmacokinetic Drug Interaction Studies with Enzalutamide. Clinical Pharmacokinetics 54:10, pages 1057-1069.
Crossref
Siji Joseph, Murali Subramanian & Smriti Khera. (2015) Simultaneous and stereospecific analysis of warfarin oxidative metabolism using 2D LC/Q-TOF. Bioanalysis 7:18, pages 2297-2309.
Crossref
Paweł Nowak, Paulina Olechowska, Mariusz Mitoraj, Michał Woźniakiewicz & Paweł Kościelniak. (2015) Determination of acid dissociation constants of warfarin and hydroxywarfarins by capillary electrophoresis. Journal of Pharmaceutical and Biomedical Analysis 112, pages 89-97.
Crossref
C. Preston Pugh, Dakota L. Pouncey, Jessica H. Hartman, Robert Nshimiyimana, Linda P. Desrochers, Thomas E. Goodwin, Gunnar Boysen & Grover P. Miller. (2014) Multiple UDP-glucuronosyltransferases in human liver microsomes glucuronidate both R- and S-7-hydroxywarfarin into two metabolites. Archives of Biochemistry and Biophysics 564, pages 244-253.
Crossref
Osama Y. Alshogran, Andrew J. Ocque, Jielu Zhao, Billy W. Day, Fran?ois A. Leblond, Vincent Pichette & Thomas D. Nolin. (2014) Determination of warfarin alcohols by ultra-high performance liquid chromatography?tandem mass spectrometry: Application to in vitro enzyme kinetic studies. Journal of Chromatography B 944, pages 63-68.
Crossref
Alexander V. LyubimovRonald E. Savage. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions 1 38 .
Baojian Wu, Kaustubh Kulkarni, Sumit Basu, Shuxing Zhang & Ming Hu. (2011) First-Pass Metabolism via UDP-Glucuronosyltransferase: a Barrier to Oral Bioavailability of Phenolics. Journal of Pharmaceutical Sciences 100:9, pages 3655-3681.
Crossref
Pauline Peltier-Pain, Shannon C. Timmons, Agn?s Grandemange, Etienne Benoit & Jon S. Thorson. (2011) Warfarin Glycosylation Invokes a Switch from Anticoagulant to Anticancer Activity. ChemMedChem 6:8, pages 1347-1350.
Crossref
Drew R. Jones, Gunnar Boysen & Grover P. Miller. (2011) Novel multi-mode ultra performance liquid chromatography–tandem mass spectrometry assay for profiling enantiomeric hydroxywarfarins and warfarin in human plasma. Journal of Chromatography B 879:15-16, pages 1056-1062.
Crossref
Trinity Vera & David E. Stec. (2010) Moderate hyperbilirubinemia improves renal hemodynamics in ANG II-dependent hypertension. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 299:4, pages R1044-R1049.
Crossref
Drew R. Jones, So-Young Kim, Michael Guderyon, Chul-Ho Yun, Jeffery H. Moran & Grover P. Miller. (2010) Hydroxywarfarin Metabolites Potently Inhibit CYP2C9 Metabolism of S -Warfarin . Chemical Research in Toxicology 23:5, pages 939-945.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.